Parmax Pharma Limited

Equities

PARMAX6

INE240T01014

Market Closed - Bombay S.E. Other stock markets 03:30:57 26/06/2024 pm IST			5-day change	1st Jan Change
30.9 ^INR	+3.55%		-1.12%	-5.13%

02/05	Parmax Pharma Limited Appoints Bhakti Aghera as Company Secretary and Compliance Officer, Effective from May 02, 2024	CI
31/01	Parmax Pharma Limited Announces the Resignation of Yash Vora as Company Secretary & Compliance Officer	CI

Parmax Pharma Limited Announces Resignation of Keyur Vora as Chief Financial Officer, Effective April 30, 2019

March 18, 2019 at 03:02 pm IST

Parmax Pharma Limited announced that Mr. Keyur Vora, Chief Financial Officer, informed the Board of Directors, at their meeting held March 18, 2019, of his decision to step down from the post of Chief Financial Officer, effective April 30, 2019.

Latest news about Parmax Pharma Limited

Parmax Pharma Limited Appoints Bhakti Aghera as Company Secretary and Compliance Officer, Effective from May 02, 2024	02/05	CI
Parmax Pharma Limited Announces the Resignation of Yash Vora as Company Secretary & Compliance Officer	31/01	CI
Parmax Pharma Limited Announces Resignation of Mr. Pramay Amritlal Chhatra as Director	27/23/27	CI
Parmax Pharma Limited Announces Resignation of Nikhil Uchat as Independent Director	25/23/25	CI
Parmax Pharma Limited Announces Demise of Asha Daftary, Independent Director	27/21/27	CI
Parmax Pharma Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended 30 June, 2021	14/21/14	CI
Parmax Pharma Limited Reports Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2021	14/21/14	CI
Parmax Pharma : Managing Director Passes Away	15/21/15	MT
Parmax Pharma Limited Announces Sad Demise of Shri Alkeshbhai Gosalia, Managing Director	15/21/15	CI
Parmax Pharma Limited cancelled the transaction announced on January 16, 2021	20/21/20	CI
Parmax Pharma Limited Approves Resignation of Alkesh Gopani from the Post of Managing Director	12/21/12	CI
Parmax Pharma Limited Approves Board Resignations	12/21/12	CI
Parmax Pharma Limited Announces Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2020	12/21/12	CI
Parmax Pharma Limited Announces Board Changes	04/21/04	CI
Parmax Pharma Limited Announces Resignation of Alkesh Gopani as Managing Director, Effective February 8, 2021	04/21/04	CI
Parmax Pharma Limited announced a financing transaction	16/21/16	CI
Parmax Pharma Limited Announces Temporary Closure of its Manufacturing Unit	25/20/25	CI
Parmax Pharma Limited Announces Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2019	13/20/13	CI
Parmax Pharma Limited Appoints Alkesh R. Gosalia as Managing Director (Finance and Operations)	27/19/27	CI
Parmax Pharma Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended 30 June, 2019	09/19/09	CI
Parmax Pharma Limited Reports Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2019	30/19/30	CI
Parmax Pharma Limited Announces Resignation of Keyur Vora as Chief Financial Officer, Effective April 30, 2019	18/19/18	CI
Parmax Pharma Limited Announces Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2018	14/19/14	CI
Parmax Pharma Limited Reports Unaudited Standalone Earnings Results for Second Quarter and Six Months Ended September 30, 2018	11/18/11	CI
Parmax Pharma Limited Announces Management Changes	09/18/09	CI

Chart Parmax Pharma Limited

Duration

Period

More charts

Company Profile

Sector

Calendar

12/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company